CALT logo

CALT EBIT

Annual EBIT

-$35.24 M
+$2.31 M+6.16%

December 31, 2023

Summary

Performance

1-Year Change

+6.16%

3-Year Change

+25.97%

5-Year Change

-131.61%

15-Year Change

-255.15%

CALT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$3.41 M

3-Year Low

-$59.15 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CALT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
CALT next annual earnings announcement has not yet been scheduled

OtherCALTprofitabilitymetrics:

Annual Revenue

$113.99 M
CALT annual revenue is $113.99 million

Annual Net Income

-$44.03 M
CALT annual net profit is -$44.03 million

Annual EBITDA

-$35.24 M
CALT annual EBITDA is -$35.24 million

Annual EPS

-$1.64
CALT annual earnings per share is -$1.64

Quarterly EBIT

-$2.95 M
+$16.70 M+84.97%

June 30, 2024

Summary

Performance

3-Month Change

+84.97%

1-Year Change

+84.97%

3-Year Change

+86.8%

5-Year Change

-132.67%

CALT Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.04 M
CALT quarterly earnings before interest & taxes is currently -132.67% below its historical high of $9.04 million

3-Year Low

-$23.09 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CALT previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
CALT next earnings announcement has not yet been scheduled

OtherCALTprofitabilitymetrics:

Quarterly Revenue

$52.48 M
CALT quarterly revenue is $52.48 million

Quarterly Net Income

-$4.45 M
CALT quarterly net profit is -$4.45 million

Quarterly EBITDA

-$2.95 M
CALT quarterly EBITDA is -$2.95 million

Quarterly EPS

-$0.17
CALT quarterly earnings per share is -$0.17

TTM EBIT

-$34.48 M
+$4.20 M+10.86%

June 30, 2024

Summary

Performance

3-Month Change

+10.86%

1-Year Change

+10.86%

3-Year Change

+45.71%

5-Year Change

-906.18%

CALT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.22 M

3-Year Low

-$70.36 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CALT previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
CALT next earnings announcement has not yet been scheduled

OtherCALTprofitabilitymetrics:

TTM Revenue

$150.81 M
CALT TTM revenue is $150.81 million

TTM Net Income

-$45.52 M
CALT TTM net profit is -$45.52 million

TTM EBITDA

-$34.48 M
CALT TTM EBITDA is -$34.48 million

TTM EPS

-$1.70
CALT TTM earnings per share is -$1.70

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$35.24 M
CALT annual earnings before interest & taxes is -$35.24 million

Annual Revenue

$113.99 M
CALT annual revenue is $113.99 million

Annual Cost Of Goods Sold

$5.71 M
CALT annual cost of goods sold is $5.71 million

Annual Operating Expenses

$143.52 M
CALT annual total operating expenses is $143.52 million

CALT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.2%+85.0%+10.9%
3 y3 years+26.0%+86.8%+45.7%
5 y5 years-131.6%-132.7%-906.2%

CALT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+67.9%-140.5%+681.9%+67.4%+104.1%
5 y5-year+934.4%+67.9%-140.5%+681.9%+906.2%+106.3%
alltimeall time+934.4%+67.9%-132.7%+681.9%+2715.7%+106.3%

Calliditas Therapeutics AB (Publ) EBIT History

DateAnnualQuarterlyTTM
Jun 2024
-
-$2.95 M(-85.0%)
-$34.48 M(-10.9%)
Mar 2024
-
-$19.65 M(-773.1%)
-$38.68 M(+6.5%)
Dec 2023
-$35.24 M(-6.2%)
$2.92 M(-119.7%)
-$36.30 M(+13.7%)
Sep 2023
-
-$14.79 M(+106.8%)
-$31.94 M(+55.0%)
Jun 2023
-
-$7.15 M(-58.6%)
-$20.60 M(-41.0%)
Mar 2023
-
-$17.28 M(-337.1%)
-$34.89 M(-12.7%)
Dec 2022
-$37.55 M(-36.5%)
$7.29 M(-310.9%)
-$39.98 M(-43.2%)
Sep 2022
-
-$3.46 M(-83.9%)
-$70.36 M(+6.6%)
Jun 2022
-
-$21.45 M(-4.1%)
-$66.00 M(+3.9%)
Mar 2022
-
-$22.37 M(-3.1%)
-$63.51 M(+7.4%)
Dec 2021
-$59.15 M(+24.3%)
-$23.09 M(-2638.3%)
-$59.15 M(+1.3%)
Sep 2021
-
$909.70 K(-104.8%)
-$58.39 M(-17.9%)
Jun 2021
-
-$18.96 M(+5.3%)
-$71.15 M(+20.4%)
Mar 2021
-
-$18.01 M(-19.3%)
-$59.07 M(+21.6%)
Dec 2020
-$47.60 M
-$22.33 M(+88.4%)
-$48.58 M(+70.1%)
Sep 2020
-
-$11.85 M(+72.1%)
-$28.57 M(+28.6%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$6.89 M(-8.5%)
-$22.21 M(+253.4%)
Mar 2020
-
-$7.52 M(+225.3%)
-$6.28 M(+83.4%)
Dec 2019
-$3.41 M(-77.6%)
-$2.31 M(-57.9%)
-$3.43 M(-43.0%)
Sep 2019
-
-$5.49 M(-160.7%)
-$6.01 M(+49.7%)
Jun 2019
-
$9.04 M(-293.9%)
-$4.02 M(-73.5%)
Mar 2019
-
-$4.66 M(-4.8%)
-$15.16 M(-0.4%)
Dec 2018
-$15.21 M(+53.3%)
-$4.90 M(+40.1%)
-$15.22 M(+0.1%)
Sep 2018
-
-$3.50 M(+66.2%)
-$15.20 M(+9.7%)
Jun 2018
-
-$2.10 M(-55.4%)
-$13.85 M(+2.6%)
Mar 2018
-
-$4.72 M(-3.2%)
-$13.51 M(+34.9%)
Dec 2017
-$9.92 M(+51.7%)
-$4.88 M(+126.8%)
-$10.01 M(+95.0%)
Sep 2017
-
-$2.15 M(+22.2%)
-$5.13 M(+72.1%)
Jun 2017
-
-$1.76 M(+43.6%)
-$2.98 M(+143.6%)
Mar 2017
-
-$1.22 M
-$1.22 M
Dec 2016
-$6.54 M(+8.1%)
-
-
Dec 2015
-$6.05 M
-
-

FAQ

  • What is Calliditas Therapeutics AB (publ) annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Calliditas Therapeutics AB (publ)?
  • What is Calliditas Therapeutics AB (publ) annual EBIT year-on-year change?
  • What is Calliditas Therapeutics AB (publ) quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Calliditas Therapeutics AB (publ)?
  • What is Calliditas Therapeutics AB (publ) quarterly EBIT year-on-year change?
  • What is Calliditas Therapeutics AB (publ) TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Calliditas Therapeutics AB (publ)?
  • What is Calliditas Therapeutics AB (publ) TTM EBIT year-on-year change?

What is Calliditas Therapeutics AB (publ) annual earnings before interest & taxes?

The current annual EBIT of CALT is -$35.24 M

What is the all time high annual EBIT for Calliditas Therapeutics AB (publ)?

Calliditas Therapeutics AB (publ) all-time high annual earnings before interest & taxes is -$3.41 M

What is Calliditas Therapeutics AB (publ) annual EBIT year-on-year change?

Over the past year, CALT annual earnings before interest & taxes has changed by +$2.31 M (+6.16%)

What is Calliditas Therapeutics AB (publ) quarterly earnings before interest & taxes?

The current quarterly EBIT of CALT is -$2.95 M

What is the all time high quarterly EBIT for Calliditas Therapeutics AB (publ)?

Calliditas Therapeutics AB (publ) all-time high quarterly earnings before interest & taxes is $9.04 M

What is Calliditas Therapeutics AB (publ) quarterly EBIT year-on-year change?

Over the past year, CALT quarterly earnings before interest & taxes has changed by +$16.70 M (+84.97%)

What is Calliditas Therapeutics AB (publ) TTM earnings before interest & taxes?

The current TTM EBIT of CALT is -$34.48 M

What is the all time high TTM EBIT for Calliditas Therapeutics AB (publ)?

Calliditas Therapeutics AB (publ) all-time high TTM earnings before interest & taxes is -$1.22 M

What is Calliditas Therapeutics AB (publ) TTM EBIT year-on-year change?

Over the past year, CALT TTM earnings before interest & taxes has changed by +$4.20 M (+10.86%)